Saxagliptin Tablet, Film Coated
Product Images NDC 65862-825

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Saxagliptin (NDC 65862-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Mean Change From Baseline In A1c In A Placebo-controlled Trial Of Saxagliptin As Add-on Combination Therapy With Metformin (Saxagliptin Figure1)

Figure 1: Mean Change From Baseline In A1c In A Placebo-controlled Trial Of Saxagliptin As Add-on Combination Therapy With Metformin (Saxagliptin Figure1)
FDA Label Image

Figure 2 (Saxagliptin Figure2)

Figure 2 (Saxagliptin Figure2)
FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablet Bottle))

Package Label-principal Display Panel (2.5 mg (30 Tablet Bottle))
FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablet Bottle))

Package Label-principal Display Panel (5 mg (30 Tablet Bottle))
FDA Label Image

Saxagliptin Monohydrate Chemical Structure (Saxagliptin Str)

Saxagliptin Monohydrate Chemical Structure (Saxagliptin Str)